Reduction in blood pressure greater with lorundrostat versus placebo in patients receiving two to five medications with BP ≥140/90 mm Hg
Many Medicaid Enrollees Have Restricted Access to SGLT2 Inhibitors, GLP-1 Receptor Agonists
Proportion of adult managed care organizations with availability varied from 24 to 100 percent for SGLT2 inhibitors, 0 to 99 percent for GLP-1 receptor agonists
New HHS Ad Campaign Urges Americans to ‘Take Back Your Health’
By I. Edwards HealthDay ReporterWEDNESDAY, April 30, 2025 (HealthDay News) — U.S. Health and Human Services Secretary Robert F. Kennedy Jr. is preparing to launch a multimillion-dollar public health campaign, …